Hepatic artery embolisation with a novel radiopaque polymer causes extended liver necrosis in pigs due to occlusion of the concomitant portal vein

Journal of Hepatology

Volumn 32, Issue 2, 2000, Pages 261-268

  Maurer, Christoph A ^a,g   Renzulli, Pietro ^a   Baer, Hans U ^a   Mettler, Daniel ^b   Uhlschmid, Georg ^e   Neuenschwander, Peter ^f   Suter, Ulrich W ^f   Triller, Jürgen ^c   Zimmermann, Arthur ^d  

^a Clin Visc and Transplant Surg   (Switzerland)

^b Research Unit   (Switzerland)

^c UNIVERSITY OF BERN   (Switzerland)

^d UNIVERSITY OF BERN   (Switzerland)

^e UNIVERSITY OF ZURICH   (Switzerland)

^f ETH ZURICH   (Switzerland)

^g Clin Visc Transplant Surg I   (Switzerland)

Author keywords

Artery; Atrophy; Collaterals; Embolisation; Liver; Polymer; Polyurethane; Portal vein

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; C REACTIVE PROTEIN; CHOLINESTERASE; DOXORUBICIN; LACTATE DEHYDROGENASE; POLYURETHAN;

ANIMAL TISSUE; ARTICLE; ARTIFICIAL EMBOLISM; BIOCOMPATIBILITY; CONTROLLED STUDY; HEART; HEPATIC ARTERY; HISTOPATHOLOGY; LASER FLOWMETER; LIVER; LIVER CIRCULATION; LIVER NECROSIS; LIVER TUMOR; LUNG; MICROCIRCULATION; NONHUMAN; PORTAL VEIN OBSTRUCTION; PRIORITY JOURNAL; SWINE;

EID: 0033968020     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(00)80071-9     Document Type: Article

References (31)

1. Ok E, Yilmaz Z, Akgun E, Sozuer EM, Yesilkaya Y, Ozturk F. Development of collaterals in intermittent and permanent ischemia of the liver. HPB Surg. 10:1996;35-40.
2. Wang LQ, Persson BG, Jeppsson B, Bengmark S. Repeated dearterializations of an experimental liver tumor: short- and long-term results. J Surg Res. 56:1994;53-59.
3. Ichihara T, Sakamoto K, Mori K, Akagi M. Transcatheter arterial chemoembolisation therapy for hepatocellular carcinoma using polylactic acid microspheres containing aclarubicin hydrochloride. Cancer Res. 49:1989;4357-4362.
4. Schubiger PA, Beer HF, Geiger L, Rosler H, Zimmermann A, Triller J, et al. 90Y-resin particles - animal experiments on pigs with regard to the introduction of superselective embolisation therapy. Int J Rad Appl Instrum. 18:1991;305-311.
5. Dakhil S, Ensminger W, Cho K, Niederhuber J, Doan K, Wheeler R. Improved regional selectivity of hepatic arterial BCNU with degradable microspheres. Cancer. 50:1982;631-635.
6. Kan Z, Sato M, Ivancev K, Uchida B, Hedgpeth P, Lunderquist A, et al. Distribution and effect of iodized poppyseed oil in the liver after hepatic artery embolisation: experimental study in several animal species. Radiology. 186:1993;861-866.
7. Sonomura T, Yamada R, Kishi K, Nishida N, Yang RJ, Sato M. Dependency of tissue necrosis on gelatin sponge particle size after canine hepatic artery embolisation. Cardiovasc Intervent Radiol. 20:1997;50-53.
8. Meade VM, Burton MA, Gray BN, Self GW. Distribution of different sized microspheres in experimental hepatic tumours. Eur J Cancer Clin Oncol. 23:1987;37-41.
9. Sonomura T. Optimal size of embolic material in transcatheter arterial embolisation of the liver. Nippon Igaku Hoshasen Gakkai Zasshi. 54:1994;489-499.
10. Link DP, Mourtada FA, Jackson J, Blashka K, Samphilipo MA. Hydrogel embolic agents. Theory and practice of adding radioopacity. Invest Radiol. 29:1994;746-751.
11. Klinger K, Zhang X, Rheda F, Gerber P, Decurtins M, Uhlschmid G, et al. Experimental pancreatic duct occlusion with polyurethane. Helv Chir Acta. 56:1989;189-193.
12. Schilling MK, Redaelli C, Maurer C, Friess H, Buchler MW. Gastric microcirculatory changes during gastric tube formation: assessment with laser Doppler flowmetry. J Surg Res. 62:1996;125-129.
13. Trinchet JC. A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma. N Engl J Med. 332:1995;1256-1261.
14. Allison DJ, Jordan H, Hennessy O. Therapeutic embolisation of the hepatic artery: a review of 75 procedures. Lancet. i:1985;595-599.
15. Dusheiko GM, Hobbs KE, Dick R, Burroughs AK. Treatment of small hepatocellular carcinomas. Lancet. 340:1992;285-288.
16. Sasaki Y, Imaoka S, Kasugai H, Fujita M, Kawamoto S, Ishiguro S, et al. A new approach to chemoembolisation therapy for hepatoma using ethiodized oil, cisplatin, and gelatin sponge. Cancer. 60:1987;1194-1203.
17. Saad B, Hirt TD, Welti M, Uhlschmid GK, Neuenschwander P, Suter UW. Development of degradable polyesterurethanes for medical applications: in vitro and in vivo evaluations. J Biomed Mater Res. 36:1997;65-74.
18. Repa I, Moradian GP, Dehner LP, Tadavarthy SM, Hunter DW, Castaneda-Zuniga WR, et al. Mortalities associated with use of a commercial suspension of polyvinyl alcohol. Radiology. 170:1989;395-399.
19. Tegtmeyer CJ, Smith TH, Shaw A, Barwick KW, Kattwinkel J. Renal infarction: a complication of gelfoam embolisation of a hemangioendothelioma of the liver. AJR. 128:1977;305-307.
20. Bengmark S, Rosengren K. Angiographic study of the collateral circulation to the liver after ligation of the hepatic artery in man. Am J Surg. 119:1970;620-624.
21. Lorigan JG, Charnsangavej C, Carrasco CH, Richli WR, Wallace S. Atrophy with compensatory hypertrophy of the liver in hepatic neoplasms: radiographic findings. AJR. 150:1988;1291-1295.
22. Liu YX, Huang ZQ, Wang YH. Effects of selective hepatic duct embolisation on normal livers, cirrhotic livers and hepatocellular carcinomas. Chung Hua I Hsueh Tsa Chih. 74:1994;467-470.
23. Demachi H, Matsui O, Kawamori Y, Ueda K, Takashima T. The protective effect of portoarterial shunts after experimental hepatic artery embolisation in rats with liver cirrhosis. Cardiovasc Intervent Radiol. 18:1995;97-101.
24. Ekelund L, Lin G, Jeppsson B. Blood supply of experimental liver tumours after intraarterial embolisation with gelfoam powder and absolute ethanol. Cardiovasc Intervent Radiol. 7:1984;234-239.
25. Matsui O, Kawamura I, Takashima T. Occurrence of an intrahepatic porto-arterial shunt after hepatic artery embolisation with gelfoam powder in rats and rabbits. Acta Radiol. 27:1986;119-122.
26. Stridbeck H, Lorelius LE, Reuter SR. Collateral circulation following repeated distal embolisation of the hepatic artery in pigs. Invest Radiol. 19:1984;179-183.
27. Mugitani T, Taniguchi H, Takada A, Yamaguchi A, Masuyama M, Hoshima M, et al. TNP-470 inhibits collateralization to complement the anti-tumour effect of hepatic artery ligation. Br J Cancer. 77:1998;638-642.
28. Nakao N, Miura K, Takahashi H, Ohnishi M, Miura T, Okamoto E, et al. Hepatocellular carcinoma: combined hepatic, arterial, and portal venous embolisation. Radiology. 161:1986;303-307.
29. Mack P, Jeppsson B, Rajszys P, Kobayashi H, Asakawa H, Bengmark S. Retarding liver cancer growth in the rat by transient repeated hepatic dearterialization. J Surg Res. 46:1989;123-128.
30. Sakamoto I, Aso N, Nagaoki K, Matsuoka Y, Uetani M, Ashizawa K, et al. Complications associated with transcatheter arterial embolisation for hepatic tumours. Radiographics. 18:1998;605-619.
31. Kan Z, Ivancev K, Hagerstrand I, Chuang VP, Lunderquist A. In vivo microscopy of the liver after injection of lipiodol into the hepatic artery and portal vein in the rat. Acta Radiol. 30:1989;419-425.